Richard M Cowett, MD Pediatrics - Neonatal-Perinatal Medicine Medicare: Not Enrolled in Medicare Practice Location: 157 Pine Hill Rd, Boxborough, MA 01719 Phone: 413-320-2085 Fax: 978-263-8709 |
News Archive
For a highly variable disease like cystic fibrosis, personalized medicine promises treatments based on individual factors, down to the molecular level. This promise is especially alluring for the treatment of children with cystic fibrosis, who are at particular risk for complications that could affect them throughout their lives.
The U.S. Food and Drug Administration announced today the approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid overdose. The newly approved product delivers 8 milligrams (mg) of naloxone into the nasal cavity. The FDA had previously approved 2 mg and 4 mg naloxone nasal spray products.
Scientists from the University of Michigan have grown the first 3D mini lungs from stem cells. The study, published in eLife, compliments other developments in the field such as growing mainly 2D structures and building lung tissue from the scaffold of donated organs.
ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that the Medical Device Network has named the LifeVest® Wearable Defibrillator as one of the five most innovative and life-changing medical devices of 2009.
More than a year into the pandemic, the disproportionate burden of COVID-19 among racial and ethnic minorities in the US has been well documented.
› Verified 5 days ago